Ventricular arrhythmias among implantable cardioverter-defibrillator recipients for primary prevention: Impact of chronic total coronary occlusion (VACTO Primary Study)

Circulation: Arrhythmia and Electrophysiology

Volumn 5, Issue 1, 2012, Pages 147-154

  Nombela Franco, Luis ^a   Mitroi, Cristina D ^a   Fernández Lozano, Ignacio ^a   García Touchard, Arturo ^a   Toquero, Jorge ^a   Castro Urda, Victor ^a   Fernández Diaz, Jose A ^a   Perez Pereira, Elena ^a   Beltrán Correas, Paula ^a   Segovia, Javier ^a   Werner, Gerald S ^b   Javier, Goicolea ^a   Luis, Alonso Pulpón ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b KLINIKUM DARMSTADT   (Germany)

Author keywords

Arrhythmias cardiac; Coronary occlusion; Implantable cardioverter defibrillators; Mortality

Indexed keywords

ADULT; ARTICLE; CARDIOVERSION; CHRONIC DISEASE; CHRONIC TOTAL CORONARY OCCLUSION; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DEVICES; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SUDDEN DEATH; TREATMENT OUTCOME;

ARRHYTHMIAS, CARDIAC; CHRONIC DISEASE; CORONARY OCCLUSION; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PRIMARY PREVENTION; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84858313624     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.111.968008     Document Type: Article

References (36)

1. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation. 1998;98: 2334-2351 (Pubitemid 28533855)
2. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Eng J Med. 1997;337:1576-1583
3. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101: 1297-1302 (Pubitemid 30158618)
4. Kuck KH, Cappato R, Siebels J, Rupperl R; CASH Investigators. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. Circulation 2000;102:748-754 (Pubitemid 30648765)
5. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883 (Pubitemid 34984635)
6. Sesselberg HW, Moss AJ, McNitt S, Zareba W, Daubert JP, Andrews ML, Hall WJ, McClinitic B, Huang DT; MADIT-II Research Group. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: A MADIT-II substudy. Heart Rhythm. 2007;4:1395-1402 (Pubitemid 47578525)
7. Santini M, Russo M, Botto G, Lunati M, Proclemer A, Schmidt B, Erdogan A, Helmling E, Rauhe W, Desaga M, Santi E, Messier M, Boriani G. Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey To Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI). Europace 2009;11:476-482
8. Stockburger M, Krebs A, Nitardy A, Habedank D, Celebi O, Knaus T, Dietz R. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death. Pacing Clin Electrophysiol. 2009; 32:S16-S20
9. Christofferson RD, Lehman KG, Martin GV, Every N, Caldwell JH, Kapadia SR. Effect of chronic total coronary occlusion on treatment strategy. Am J Cardiol. 2005;95:1088-1091 (Pubitemid 40544315)
10. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW; SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961-972
11. Claessen BE, van der Schaaf TW, Verouden NJ, Stegenga NK, Engstrom AE, Sjauw KD, Kikkert WJ, Vis MM, Baan J Jr, Koch KT, de Winter RJ, Tijssen JG, Piek JJ, Henriques JP. Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention. J Am Coll Cardiol Cardiovasc Interv. 2009;2:1128-1134
12. Aziz S, Stables RH, Grayson AD, Perry RA, Ramsdale DR. Percutaneous coronary intervention for chronic total occlusions improved survival for patients with successful revascularization compared to a failed procedure. Catheter Cardiovasc Interv. 2007;70:15-20 (Pubitemid 47035987)
13. Suero JA, Marso SP, Jones PG, Laster SB, Huber KC, Giorgi LV, Johnson WL, Rutherford BD. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native arteries: A 20-year experience. J Am Coll Cardiol. 2001;38:409-414 (Pubitemid 32721768)
14. Joyal D, Afilalo J, Rinfret S. Effectiveness of recanalization of chronic total occlusions: A systematic review and meta-analysis. Am Heart J 2010;160:179-187
15. Steinberg JS, Hochman JS, Morgan CD, Dorian P, Naylor CD, Theroux P, Topol EJ, Armstrong PW. Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic Efficacy. Circulation 1994;90:746-752 (Pubitemid 24242740)
16. Boehrer JD, Glamann DB, Lange RA, Willard JE, Brogan WC III, Eichhorn EJ, Grayburn PA, Anwar A, Hillis LD. Effect of coronary angioplasty on late potentials one to two weeks after acute myocardial infarction. Am J Cardiol. 1992;70:1515-1519 (Pubitemid 23006061)
17. Di Mario C, Werner GS, Sianos G, Galassi AR, Büttner J, Dudek D, Chevalier B, Lefevre T, Schofer J, Koolen J, Sievert H, Reimers B, Fajadet J, Colombo A, Gershlick A, Serruys PW, Reifart N. European perspective in the recanalisation of Chronic Total Occlusions (CTO): Consensus document from the EuroCTO Club. EuroInterv. 2007;3: 30-43
18. Verma A, Sarak B, Kaplan AJ, Oosthuizen R, Beardsall M, Wulffhart Z, Higenbottam J, Khaykin Y. Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy. Pacing Clin Electrophysiol 2010;33:320-329
19. Otmani A, Trinquart L, Marijon E, Lavergne T, Waintraub X, Lepillier A, Chatellier G, Le Heuzey JY; EVADEF Investigators. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: Results from the EVADEF cohort study. Am Heart J. 2009;158:230-237
20. Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, Feldman AM, Galle E, Ecklund F. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation. 2006;114:2766-2772 (Pubitemid 46018278)
21. Desai H, Aronow WS, Ahn C, Gandhi K, Hussain S, Lai HM, Sharma M, Frishman WH, Cohen M, Sorbera C. Risk factors for appropriate cardioverter-defibrillator shocks, inappropriate cardioverter-defibrillator shocks, and time to mortality in 549 patients with heart failure. Am J Cardiol. 2010;105:1336-1338
22. Werner GS, Gitt AK, Zeymer U, Juenger C, Towae F, Wienbergen H, Senges J. Chronic total coronary occlusions in patients with stable angina pectoris: Impact on therapy and outcome in present day clinical practice. Clin Res Cardiol. 2009;98:435-441
23. Werner GS, Figulla HR. Direct assessment of coronary steal and associated changes of collateral hemodynamics in chronic total coronary occlusions. Circulation. 2002;106:435-440 (Pubitemid 34803687)
24. Werner GS, Fritzenwanger M, Prochnau D, Schwarz G, Ferrari M, Aarnoudse W, Pijls NH, Figulla HR. Determinants of coronary steal in chronic total coronary occlusions donor artery, collateral, and microvascular resistance. J Am Coll Cardiol. 2006;48:51-58 (Pubitemid 43929223)
25. Meissner MD, Akhtar M, Lehmann MH. Nonischemic sudden tachyarrhythmic death in atherosclerotic heart disease. Circulation. 1991;84: 905-912
26. Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, Kralovec S, Sediva L, Ruskin JN, Josephson ME. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357:2657-2665
27. Kamphuis HC, de Leeuw JR, Derksen R, Hauer RN, Winnubst JA. Implantable cardioverter defibrillator recipients: Quality of life in recipients with and without ICD shock delivery: A prospective study. Europace. 2003;5:381-389 (Pubitemid 37336967)
28. Hermosillo AG, Dorado M, Casanova JM, Ponce de Leon S, Cossio J, Kersenovich S, Colin L, Iturralde P. Influence of infarct-related artery patency on the indexes of parasympathetic activity and prevalence of late potentials in survivors of acute myocardial infarction. J Am Coll Cardiol 1993;22:695-706 (Pubitemid 23256928)
29. Mortara A, Specchia G, La Rovere MT, Bigger JT Jr, Marcus FI, Camm JA, Hohnloser SH, Nohara R, Schwartz PJ. Patency of infarct-related artery. Effect of restoration of anterograde flow on vagal reflexes. ATRAMI (Automatic Tone and Reflexes After Myocardial Infarction) Investigators. Circulation. 1996;93:1114-1122 (Pubitemid 26087014)
30. Rashba EJ, Lamas GA, Couderc JP, Hollist SM, Dzavik V, Ruzyllo W, Fridrich V, Buller CE, Forman SA, Kufera JA, Carvalho AC, Hochman JS; OAT-EP Investigators. Electrophysiological effects of late percutaneous coronary intervention for infarct-related coronary artery occlusion: The Occluded Artery Trial-Electrophysiological Mechanisms (OAT-EP). Circulation. 2009;119:779-787
31. Werner GS, Di Mario C, Galassi AR, Gershlick A, Reimers B, Sianos G, Sievert H, Lefevre T, Reifart N; EuroCTO Club. Chronic total coronary occlusions and the occluded artery trial. A critical appraisal. EuroIntervention. 2008;4:23-27
32. Stone GW, Kandzari DE, Mehran R, Colombo A, Schwartz RS, Bailey S, Moussa I, Teirstein PS, Dangas G, Baim DS, Selmon M, Strauss BH, Tamai H, Suzuki T, Mitsudo K, Katoh O, Cox DA, Hoye A, Mintz GS, Grube E, Cannon LA, Reifart NJ, Reisman M, Abizaid A, Moses JW, Leon MB, Serruys PW. Percutaneous recanalization of chronically occluded coronary arteries: A consensus document: Part I. Circulation 2005;112:2364-2372 (Pubitemid 41464580)
33. Hoye A, van Domburg RT, Sonnenschein K, Serruys PW. Percutaneous coronary intervention for chronic total occlusions: The Thoraxcenter experience 1992-2002. Eur Heart J. 2005;26:2630-2636 (Pubitemid 41746683)
34. Olivari Z, Rubartelli P, Piscione F, Ettori F, Fontanelli A, Salemme L, Giachero C, Di Mario C, Gabrielli G, Spedicato L, Bedogni F; TOAST-GISE Investigators. Immediate and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions. J Am Coll Cardiol. 2003;41:1672-1678
35. Safley DM, House JA, Marso SP, Grantham JA, Rutherford BD. Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: Variability by target vessel. J Am Coll Cardiol Cardiovasc Interv. 2008;1:295-302 (Pubitemid 351804199)
36. Surber R, Schwarz G, Figulla HR, Werner GS. Resting 12-lead electrocardiogram as a reliable predictor of functional recovery after recanalization of chronic total coronary occlusions. Clin Cardiol 2005;28:293-297. (Pubitemid 40800555)